A detailed history of Simplify Asset Management Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Simplify Asset Management Inc. holds 1,562 shares of BIIB stock, worth $271,459. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,562
Holding current value
$271,459
% of portfolio
0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$190.52 - $236.72 $297,592 - $369,756
1,562 New
1,562 $362,000
Q2 2023

Aug 14, 2023

BUY
$275.25 - $318.06 $822,722 - $950,681
2,989 New
2,989 $851,000
Q4 2022

Feb 10, 2023

BUY
$252.44 - $306.72 $1.47 Million - $1.79 Million
5,836 New
5,836 $1.62 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Simplify Asset Management Inc. Portfolio

Follow Simplify Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.